Considerations for High-Risk Populations: Response to Zeller's The Future of Nicotine Regulation: Key Questions and Challenges

Research output: Contribution to journalLetter

Abstract

In this issue of the Journal, Zeller provides a commentary on the US Food and Drug Administration’s (FDA) new tobacco regulatory strategy that includes a proposal to reduce nicotine levels in combustible tobacco cigarettes to very low levels and to support nicotine delivery products that deliver nicotine to smokers at lower harm levels (such as electronic cigarettes).1 Very low nicotine content (VLNC) in cigarettes reduces their addictiveness, which can help current smokers to quit and prevent youth from becoming addicted. Zeller points out that the FDA estimates in 1 year of implementation, this strategy may help an additional five million adult smokers to quit. Zeller also outlines some important challenges and issues for further consideration. One issue not outlined is the potential impact of VLNC cigarettes on high-risk population groups, with high smoking prevalence rates.

Original languageEnglish
Pages (from-to)342-343
Number of pages2
JournalNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Volume21
Issue number3
DOIs
Publication statusPublished - Mar 2019
Externally publishedYes

Keywords

  • Letter
  • Mitch Zeller
  • High-Risk Populations
  • Nicotine regulation
  • US Food and Drug Administration’s (FDA)
  • tobacco regulatory strategy
  • Very low nicotine content (VLNC)
  • VLNC cigarettes
  • nicotine replacement therapy (NRT)

Fingerprint

Dive into the research topics of 'Considerations for High-Risk Populations: Response to Zeller's The Future of Nicotine Regulation: Key Questions and Challenges'. Together they form a unique fingerprint.

Cite this